Center for Human Reproduction

Center for Human Reproduction World-renowned experts in infertility treatment, specializing in pregnancy for difficult infertility cases and women 40+.

Internationally recognized for infertility treatment and research, CHR is known worldwide as the infertility center of last resort. One of the first IVF centers established in the U.S., the Center for Human Reproduction (CHR) offers all aspects of modern infertility treatment. Through extensive research and clinical efforts, CHR has developed special knowledge and expertise in treating diminished

ovarian reserve, a classic finding in older women and also in younger women with prematurely aging ovaries. Our pioneering research into IVF with DHEA supplementation — a treatment that CHR studies have found can double the IVF pregnancy chances in women with diminished ovarian reserve — has been noted worldwide, and one third of all infertility centers now use the technique. CHR also offers one of the world’s largest and most diverse egg donor programs. Located in Manhattan, New York City (NYC), approximately half of our patients are local, with another half hailing from other states and abroad. We invite you to learn more about CHR’s clinical offerings, treatments, research, and educational activities by exploring our extensive website. Feel free to contact us with any questions!

This week, we’re highlighting our partner, The Foundation for Reproductive Medicine, a nonprofit advancing research that...
04/24/2026

This week, we’re highlighting our partner, The Foundation for Reproductive Medicine, a nonprofit advancing research that helps patients all around the world.

By supporting fertility research and education, we’re working toward better science, deeper understanding, and personalized care.

Male factor infertility plays a role in nearly half of all fertility challenges, but it’s often underdiagnosed and under...
04/23/2026

Male factor infertility plays a role in nearly half of all fertility challenges, but it’s often underdiagnosed and undertreated.

At CHR, our IRB-approved MENPAT clinical trial is designed to go deeper to address s***m quality, targeting DNA integrity and oxidative stress, key drivers of male infertility.

This 90-day nutritional protocol is aligned with the full cycle of s***matogenesis, using a targeted combination of antioxidants and metabolic support to improve s***m parameters.

This is precision reproductive care for both partners.

1 in 6 people worldwide experience infertility.Today, we wear orange to raise awareness, engage in conversation, and sup...
04/22/2026

1 in 6 people worldwide experience infertility.

Today, we wear orange to raise awareness, engage in conversation, and support those on this journey. 🧡

04/21/2026

It's National Infertility Awareness Week! This week, we stand with everyone navigating the challenges of infertility.

Tune into this video to learn about why we don't believe in unexplained infertility at the CHR and check out our YouTube to watch the full video and be part of the conversation.

1 in 6 people experience infertility. As we kick off National Infertility Awareness Week, let’s come together to raise a...
04/20/2026

1 in 6 people experience infertility. As we kick off National Infertility Awareness Week, let’s come together to raise awareness, share knowledge, and support everyone on this journey.

Are you ready for FRMC 2026? It's time to secure your spot at the forefront of reproductive medicine. Our Early Bird tic...
04/17/2026

Are you ready for FRMC 2026? It's time to secure your spot at the forefront of reproductive medicine. Our Early Bird tickets are on sale now, and you won't want to miss out on this event!

Book your tickets now and be part of this groundbreaking conference. Use the link below or click the link in our bio to purchase Early Bird tickets. See you there! 🌟

https://whova.com/portal/registration/GM2LL8NP2n7gCLCnO9y-/

Our Second Opinion Program is here provide extra guidance so that you can move forward with clarity and confidence. ...
04/17/2026

Our Second Opinion Program is here provide extra guidance so that you can move forward with clarity and confidence.

At CHR, we are exploring one of the most important questions in reproductive medicine: can we improve oocyte quality by ...
04/16/2026

At CHR, we are exploring one of the most important questions in reproductive medicine: can we improve oocyte quality by optimizing how follicles function at a cellular level?

Our IRB-approved Sirolimus Cycle Priming trial targets the mTOR pathway, a key regulator of cellular aging, metabolism, and oxidative stress. When dysregulated, this pathway may contribute to poor egg quality, even in women with normal ovarian reserve.

By using a short-term course of Sirolimus prior to stimulation, we aim to create a healthier follicular environment and improve embryo development outcomes.

This study is designed for patients who “look good on paper” but have struggled with poor IVF results, bringing precision, mechanism-based care to a complex clinical problem.

Thank you for sharing your experience and for trusting CHR! 🤍
04/14/2026

Thank you for sharing your experience and for trusting CHR! 🤍

04/10/2026

Thinking about egg freezing but don’t know where to start? Watch this video for a breakdown.

The biggest takeaway is that you have more control than you think. Save this for later & share it with a friend who’s been curious about fertility preservation!

We're hiring for international healthcare professionals! If you're interested, please send your resume and a brief intro...
04/09/2026

We're hiring for international healthcare professionals!

If you're interested, please send your resume and a brief introduction to: jtapper@thechr.com.

At CHR, we are pushing the boundaries of reproductive science to improve outcomes for patients with diminished ovarian r...
04/09/2026

At CHR, we are pushing the boundaries of reproductive science to improve outcomes for patients with diminished ovarian reserve (DOR).
Our newest IRB-approved clinical trial explores the role of G-CSF ovarian priming: a novel approach designed to optimize the ovarian environment before IVF stimulation begins.

Traditionally used to support the endometrium, G-CSF is now being studied for its potential effects on the o***y, including improving blood flow, supporting early follicle development, and reducing follicular loss. Our protocol applies a targeted luteal-phase regimen to enhance follicle recruitment ahead of the next cycle.

This is translational ART at its best - where emerging science meets real-world patient care.

Address

21 E. 69th Street
New York, NY
10021

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm
Saturday 8:30am - 12pm
Sunday 8:30am - 12pm

Website

https://www.foundati

Alerts

Be the first to know and let us send you an email when Center for Human Reproduction posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Center for Human Reproduction:

Shortcuts

Featured

Share

Category